Literature DB >> 33572083

Molecular Mechanisms of Anti-Melanogenic Gedunin Derived from Neem Tree (Azadirachta indica) Using B16F10 Mouse Melanoma Cells and Early-Stage Zebrafish.

Hwang-Ju Jeon1, Kyeongnam Kim1, Chaeeun Kim2, Myoung-Jin Kim1, Tae-Oh Kim3, Sung-Eun Lee1,2.   

Abstract

Melanogenesis represents a series of processes that produce melanin, a protective skin pigment (against ultraviolet rays), and determines human skin color. Chemicals reducing melanin production have always been in demand in the cosmetic market because of skincare interests, such as whitening. The main mechanism for inhibiting melanin production is the inhibition of tyrosinase (TYR), a key enzyme for melanogenesis. Here, we evaluated gedunin (Ged), a representative limonoid, for its anti-melanogenesis action. Melanin production in vitro was stimulated by alpha-melanocyte stimulating hormone (α-MSH) in B16F10 mouse melanoma cells. Ged reduced α-MSH-stimulated melanin production, inhibiting TYR activity and protein amount. We confirmed this result in vivo in a zebrafish model for melanogenesis. There was no sign of toxicity and malformation of zebrafish embryos during development in all treated concentrations. Ged reduced the number of produced zebrafish embryo pigment dots and melanin contents of embryos. The highly active concentration of Ged (100 µM) was much lower than the positive control, kojic acid (8 mM). Hence, Ged could be a fascinating candidate for anti-melanogenesis reagents.

Entities:  

Keywords:  ACTH; ASP; CREB; DQ; MC1R; MITF; TRP-1; TRP-2; TYR; adrenocorticotropic hormone; agouti signaling protein; cAMP; cAMP response element; cyclic adenosine monophosphate; dopaquinone; melanocortin 1 receptor; microphthalmia-associated transcription factor; tyrosinase; tyrosinase-related protein 1; tyrosinase-related protein 2; α-MSH; α-melanocyte stimulating hormone

Year:  2021        PMID: 33572083      PMCID: PMC7914499          DOI: 10.3390/plants10020330

Source DB:  PubMed          Journal:  Plants (Basel)        ISSN: 2223-7747


  32 in total

1.  Downregulation of melanocyte-specific facultative melanogenesis by 4-hydroxy-3-methoxycinnamaldehyde acting as a cAMP antagonist.

Authors:  Eunmiri Roh; In-Yeong Jeong; Hyoeun Shin; Sukgil Song; Nam Doo Kim; Sang-Hun Jung; Jin Tae Hong; Seung Ho Lee; Sang-Bae Han; Youngsoo Kim
Journal:  J Invest Dermatol       Date:  2013-08-07       Impact factor: 8.551

2.  Gedunin inactivates the co-chaperone p23 protein causing cancer cell death by apoptosis.

Authors:  Chaitanya A Patwardhan; Abdul Fauq; Laura B Peterson; Charles Miller; Brian S J Blagg; Ahmed Chadli
Journal:  J Biol Chem       Date:  2013-01-25       Impact factor: 5.157

Review 3.  "Transcription physiology" of pigment formation in melanocytes: central role of MITF.

Authors:  Jiri Vachtenheim; Jan Borovanský
Journal:  Exp Dermatol       Date:  2010-02-25       Impact factor: 3.960

4.  Resveratrol-mediated inhibition of cyclooxygenase-2 in melanocytes suppresses melanogenesis through extracellular signal-regulated kinase 1/2 and phosphoinositide 3-kinase/Akt signalling.

Authors:  Seong-Hui Eo; Song Ja Kim
Journal:  Eur J Pharmacol       Date:  2019-08-01       Impact factor: 4.432

5.  Gedunin Binds to Myeloid Differentiation Protein 2 and Impairs Lipopolysaccharide-Induced Toll-Like Receptor 4 Signaling in Macrophages.

Authors:  Perla Villani Borges; Katelim Hottz Moret; Clarissa Menezes Maya-Monteiro; Franklin Souza-Silva; Carlos Roberto Alves; Paulo Ricardo Batista; Ernesto Raúl Caffarena; Patrícia Pacheco; Maria das Graças Henriques; Carmen Penido
Journal:  Mol Pharmacol       Date:  2015-09-01       Impact factor: 4.436

6.  Melanocortin receptor accessory protein 2 (MRAP2) interplays with the zebrafish melanocortin 1 receptor (MC1R) but has no effect on its pharmacological profile.

Authors:  Raúl Cortés; Maria Josep Agulleiro; Sandra Navarro; Raúl Guillot; Elisa Sánchez; José Miguel Cerdá-Reverter
Journal:  Gen Comp Endocrinol       Date:  2014-04-05       Impact factor: 2.822

7.  In Vitro Anticancer Effect of Gedunin on Human Teratocarcinomal (NTERA-2) Cancer Stem-Like Cells.

Authors:  Luxmiga Tharmarajah; Sameera Ranganath Samarakoon; Meran Keshawa Ediriweera; Poorna Piyathilaka; Kamani Hemamamla Tennekoon; Kanishka Sithira Senathilake; Umapriyatharshini Rajagopalan; Prasanna Bandula Galhena; Ira Thabrew
Journal:  Biomed Res Int       Date:  2017-06-07       Impact factor: 3.411

8.  Glucose starvation induces LKB1-AMPK-mediated MMP-9 expression in cancer cells.

Authors:  Hitoshi Endo; Satoshi Owada; Yutaka Inagaki; Yukari Shida; Masayuki Tatemichi
Journal:  Sci Rep       Date:  2018-07-04       Impact factor: 4.379

Review 9.  Mechanisms regulating melanogenesis.

Authors:  Inês Ferreira dos Santos Videira; Daniel Filipe Lima Moura; Sofia Magina
Journal:  An Bras Dermatol       Date:  2013 Jan-Feb       Impact factor: 1.896

10.  Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes.

Authors:  C Bertolotto; P Abbe; T J Hemesath; K Bille; D E Fisher; J P Ortonne; R Ballotti
Journal:  J Cell Biol       Date:  1998-08-10       Impact factor: 10.539

View more
  3 in total

Review 1.  The Challenging Melanoma Landscape: From Early Drug Discovery to Clinical Approval.

Authors:  Mariana Matias; Jacinta O Pinho; Maria João Penetra; Gonçalo Campos; Catarina Pinto Reis; Maria Manuela Gaspar
Journal:  Cells       Date:  2021-11-09       Impact factor: 6.600

2.  Discovery and identification of potential anti-melanogenic active constituents of Bletilla striata by zebrafish model and molecular docking.

Authors:  Yiyuan Luo; Juan Wang; Shuo Li; Yue Wu; Zhirui Wang; Shaojun Chen; Hongjiang Chen
Journal:  BMC Complement Med Ther       Date:  2022-01-07

3.  Identification of Sitogluside as a Potential Skin-Pigmentation-Reducing Agent through Network Pharmacology.

Authors:  Haoran Guo; Hongliang Zeng; Chuhan Fu; Jinhua Huang; Jianyun Lu; Yibo Hu; Ying Zhou; Liping Luo; Yushan Zhang; Lan Zhang; Jing Chen; Qinghai Zeng
Journal:  Oxid Med Cell Longev       Date:  2021-09-23       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.